• Call 2024

    The fifth call dedicated to paediatric brain tumour led to the selection, by independent international experts, of eight innovative research projects for a total amount of 10,7 million euros. These projects include 6 Translational Researchs and 2 Clinical Trials.

     

  • Call 2023

    The fourth call led to the selection, by independent international experts, of nine innovative research projects of European scope for a total amount of 4,4 million euros. These projects include 8 Translational Researchs and 1 Clinical Trial.

     

  • Call 2022

    The third call led to the selection, by independent international experts, of 10 innovative research projects of European scope for a total amount of 7,25 million euros. This call includes 3 additional projects selected early 2023 for a total of 7 Translational Researchs and 3 Clinical Trials.

  • Call 2021

    In 2021, the second call led to the selection of five innovative projects for a total amount of 3,45 million euros. These 5 projects are about the following diseases: B-cell non-Hodgkin’s lymphoma, Ewing’s sarcoma, medulloblastoma and neuroblastoma (2 projects). They include 3 x Translational Researchs and 2 x Clinical Trials.

  • Call 2020

    In 2020, the first call led to the selection of six innovative projects for a total amount of 3,08 million euros. These 6 projects are about the following diseases: high-grade gliomas (2 projects), acute myeloid leukaemia, rhabdoid tumours, osteosarcoma and neuroblastomas. They include 5 Translational Researchs and 1 Clinical Trial.

Contact

Programme support and management is provided by the European Science Foundation, which is the intermediary with the funding organisations.

For further information about this announcement of opportunity please contact Fight Kids Cancer at ESF: fightkidscancer@esf.org

Contact form